These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15508308)

  • 1. Automated peak tracking for comprehensive impurity profiling in orthogonal liquid chromatographic separation using mass spectrometric detection.
    Xue G; Bendick AD; Chen R; Sekulic SS
    J Chromatogr A; 2004 Oct; 1050(2):159-71. PubMed ID: 15508308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of pharmaceutical impurities using multi-heartcutting 2D LC coupled with UV-charged aerosol MS detection.
    Zhang K; Li Y; Tsang M; Chetwyn NP
    J Sep Sci; 2013 Sep; 36(18):2986-92. PubMed ID: 23821312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ultra-high performance methods in liquid and supercritical fluid chromatography coupled to electrospray ionization - mass spectrometry for impurity profiling of drug candidates.
    Lemasson E; Bertin S; Hennig P; Lesellier E; West C
    J Chromatogr A; 2016 Nov; 1472():117-128. PubMed ID: 27793392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic approach to development of liquid chromatographic impurity methods for pharmaceutical analysis.
    Stafford JD; Maloney TD; Myers DP; Cintron JM; Castle BC
    J Pharm Biomed Anal; 2011 Sep; 56(2):280-92. PubMed ID: 21665403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
    Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
    J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impurity profile tracking for active pharmaceutical ingredients: case reports.
    Zhou L; Mao B; Reamer R; Novak T; Ge Z
    J Pharm Biomed Anal; 2007 Jun; 44(2):421-9. PubMed ID: 17142001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of hyphenated LC-MS techniques in pharmaceutical analysis.
    Ermer J; Vogel M
    Biomed Chromatogr; 2000 Oct; 14(6):373-83. PubMed ID: 11002275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated molecular weight assignment of electrospray ionization mass spectra.
    Williams JD; Weiner BE; Ormand JR; Brunner J; Thornquest AD; Burinsky DJ
    Rapid Commun Mass Spectrom; 2001; 15(24):2446-55. PubMed ID: 11746916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capillary electrophoresis-mass spectrometry in impurity profiling of pharmaceutical products.
    Visky D; Jimidar I; Van Ael W; Vennekens T; Redlich D; De Smet M
    Electrophoresis; 2005 Apr; 26(7-8):1541-9. PubMed ID: 15776482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an improved general unknown screening procedure using liquid chromatography-electrospray-mass spectrometry by comparison with gas chromatography and high-performance liquid-chromatography--diode array detection.
    Saint-Marcoux F; Lachâtre G; Marquet P
    J Am Soc Mass Spectrom; 2003 Jan; 14(1):14-22. PubMed ID: 12504330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An automated high throughput liquid chromatography-mass spectrometry process to assess the metabolic stability of drug candidates.
    Drexler DM; Belcastro JV; Dickinson KE; Edinger KJ; Hnatyshyn SY; Josephs JL; Langish RA; McNaney CA; Santone KS; Shipkova PA; Tymiak AA; Zvyaga TA; Sanders M
    Assay Drug Dev Technol; 2007 Apr; 5(2):247-64. PubMed ID: 17477833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the detection of degradants and impurities in pharmaceutical drug products by applying mass spectral and chromatographic searching.
    Freed AL; Kale U; Ando H; Rossi DT; Kingsmill CA
    J Pharm Biomed Anal; 2004 Jun; 35(4):727-38. PubMed ID: 15193717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC-MS characterization of trace impurities contained in calcium folinate.
    Francese G; Corana F; Meneghetti O; Marazza F
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):757-63. PubMed ID: 15927438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug impurity profiling by capillary electrophoresis/mass spectrometry using various ionization techniques.
    Hommerson P; Khan AM; Bristow T; Harrison MW; de Jong GJ; Somsen GW
    Rapid Commun Mass Spectrom; 2009 Sep; 23(18):2878-84. PubMed ID: 19670338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capillary electrophoresis-mass spectrometry for impurity profiling of basic pharmaceuticals using non-volatile background electrolytes.
    van Wijk AM; Muijselaar PG; Stegman K; de Jong GJ
    J Chromatogr A; 2007 Aug; 1159(1-2):175-84. PubMed ID: 17588593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supercritical fluid chromatography-photodiode array detection-electrospray ionization mass spectrometry as a framework for impurity fate mapping in the development and manufacture of drug substances.
    Pirrone GF; Mathew RM; Makarov AA; Bernardoni F; Klapars A; Hartman R; Limanto J; Regalado EL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1080():42-49. PubMed ID: 29477066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple and efficient approach to reversed-phase HPLC method screening.
    Biswas KM; Castle BC; Olsen BA; Risley DS; Skibic MJ; Wright PB
    J Pharm Biomed Anal; 2009 Apr; 49(3):692-701. PubMed ID: 19181471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.